Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees

The following table summarizes the stock-based compensation expense for stock options granted to employees and non-employees:


		Three months ended June 30,								Six months ended June 30,
		2026				2025				2026				2025
Research and development*		$	1,485,105			$	1,655,836			$	3,275,805			$	2,109,022
Selling, general and administrative			3,860,905				2,552,906				7,629,971				4,141,916
Total stock-based compensation expense		$	5,346,010			$	4,208,742			$	10,905,776			$	6,250,938

*Includes $0 and $0.4 million for the three and six months ended June 30, 2026, respectively, and $0.7 million and $1.0 million for the three and six months ended June 30, 2025, respectively, related to the restricted stock awards issued in connection with the acquisition of CorHepta.